ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 685–696 of 2020 project topics
Factor V Leiden and Prothrombin G20210A Detection Platform
A rapid molecular diagnostic SaaS platform that identifies Factor V Leiden and Prothrombin G20210A mutations through next-generation sequencing with automated variant interpretation. This enables clinical laboratories and hospitals to offer thrombosis risk stratification services with 48-hour turnaround, commanding premium reimbursement rates from insurance providers.
Genetic Basis of Bleeding and Clotting Disorders Click to view more details →
Fibrinogen Dysfunction Gene Sequencing and Risk Stratification Tool
An integrated bioinformatics platform that sequences AFM, FGB, and FGG genes to classify fibrinogen deficiencies and dysfibrinogenemias with predictive bleeding risk algorithms. Laboratories can monetize this through reflex testing revenue and patient stratification services for personalized transfusion protocols worth $3,000-$5,000 per case.
Genetic Basis of Bleeding and Clotting Disorders Click to view more details →
Protein C and Protein S Deficiency Automated Screening Solution
A cloud-based laboratory information system that combines genetic sequencing with functional assay data to diagnose Type I, II, and III protein C and S deficiencies. This solution generates recurring subscription revenue from regional laboratories while enabling risk-based anticoagulation therapy recommendations that reduce bleeding complications by 35%.
Genetic Basis of Bleeding and Clotting Disorders Click to view more details →
Antithrombin III Gene Mutation Commercial Testing and Reporting Suite
A white-label molecular testing platform that identifies SERPINC1 mutations causing antithrombin deficiency with customizable clinical reports for direct-to-consumer and B2B distribution. The platform generates revenue through test kit sales, laboratory partnerships, and data licensing to pharmaceutical companies developing novel anticoagulants.
Genetic Basis of Bleeding and Clotting Disorders Click to view more details →
Bleeding Disorder Gene Panel Commercial Licensing and Syndication
A comprehensive multi-gene sequencing panel covering 40+ genes associated with inherited bleeding disorders, offered through SaaS licensing to diagnostic laboratories and hospital networks. This recurring revenue model delivers $50,000+ annual contracts while enabling laboratories to expand their test menu without internal R&D investment.
Genetic Basis of Bleeding and Clotting Disorders Click to view more details →
Thrombotic and Bleeding Risk Polygenic Scoring Commercial Analytics Engine
An AI-powered analytics platform that calculates polygenic risk scores integrating multiple common and rare variants to predict individualized bleeding and clotting risk profiles. Pharmaceutical companies, wellness platforms, and insurance providers adopt this as a value-added service generating $2-$10 per patient analysis at scale.
Genetic Basis of Bleeding and Clotting Disorders Click to view more details →
Biobank Cohort Establishment for Genetic Studies
Designing and implementing population biobank cohorts with linked health records for large-scale genetic epidemiology and pharmacogenomics studies.
Genetic Epidemiology Study Designs Click to view more details →
Case-Control Study Design for Genetic Association
Designing genetically matched case-control studies with appropriate power calculations and population stratification controls for genetic association testing.
Genetic Epidemiology Study Designs Click to view more details →
Family-Based Study Designs for Rare Variants
Applying transmission disequilibrium tests and family-based association methods for robust rare variant testing in families with common disease.
Genetic Epidemiology Study Designs Click to view more details →
Mendelian Randomization Instrument Selection
Identifying valid genetic instrumental variables and evaluating pleiotropy for robust Mendelian randomization causal inference in epidemiological studies.
Genetic Epidemiology Study Designs Click to view more details →
Genome-Wide Association Study Platform Automation
Cloud-based SaaS platform that automates GWAS data processing, quality control, and statistical analysis pipelines for large-scale genetic studies. Delivers recurring revenue through subscription licensing while reducing study completion time by 60% and enabling researchers to handle millions of SNPs without infrastructure investment.
Genetic Epidemiology Study Designs Click to view more details →
Population Stratification Detection and Correction Software
Proprietary algorithmic tool that identifies and corrects population substructure artifacts in genetic association studies using principal component analysis and ancestry inference. Generates B2B SaaS revenue by preventing false positive associations that could compromise drug development timelines and regulatory submissions.
Genetic Epidemiology Study Designs Click to view more details →